SC II Acquisition Corp. (SCII) is a special purpose acquisition company (SPAC) focused on merging with high-growth enterprises, particularly in the technology and healthcare sectors. Leveraging a seasoned management team with a proven history of successful investments and strategic transactions, SCII aims to capitalize on emerging market trends to maximize shareholder value. As the SPAC landscape continues to evolve, the company is strategically positioned to pursue innovative opportunities that drive substantial growth and deliver strong returns for investors.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.04 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $17.50M |
| Float | $14.29M |
| % Insiders | 0.00% |
| % Institutions | 91.13% |
Volatility is currently contracting
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SCII and any ticker you trade — then tracks every position and per-strategy win rate.